POSEIDA

What this means for you

Registered since 22 Jul 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

90660241

Registration number

7870558

Mark type

Stylized text

Filed

21 Apr 2021

Published for opposition

25 Jan 2022

Registered

22 Jul 2025

Attorney of record

Brendan J. Hughes

Goods and services

• Class 001 — Chemicals: Kits comprised of genetically engineered cell lines, reagents, enzyme substrates and chemical preparations for research purposes; reagents and kits comprising reagents for research use in connection with cell manipulation, cell transformation, genomic editing and analysis; reagents, nucleic acids, and nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modifications for use in the fields of scientific research, clinical research, and scientific diagnostics research

Owner

• Poseida Therapeutics, Inc., San Diego, CA, US
• Poseida Therapeutics, Inc., San Diego, CA, US
• Poseida Therapeutics, Inc., San Diego, CA, US

Prosecution history

• 22 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
• 22 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
• 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 29 Jun 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 24 Jun 2025 — STATEMENT OF USE PROCESSING COMPLETE
• 24 Mar 2025 — USE AMENDMENT FILED
• 24 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 24 Mar 2025 — TEAS STATEMENT OF USE RECEIVED
• 11 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 11 Sept 2024 — SOU EXTENSION 5 GRANTED
• 11 Sept 2024 — SOU EXTENSION 5 FILED
• 11 Sept 2024 — SOU TEAS EXTENSION RECEIVED
• 13 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 12 Mar 2024 — SOU EXTENSION 4 GRANTED
• 12 Mar 2024 — SOU EXTENSION 4 FILED